Gastrointestinal side effects on these drugs are usually a dose-escalation problem, which is why most of what is written about them concerns the first few months. This case is about the other moment nobody plans for: coming back after a gap — the one the stop-or-continue framing leaves out entirely.
What happened
The patient had obesity, hypertension, high cholesterol and anxiety, and had been on semaglutide 2.4 mg for roughly a year with good tolerance and successful weight loss. [1] The treatment was interrupted for five weeks during Ramadan.
She restarted at the dose she had been on. Within a day she had severe nausea, vomiting and diarrhea, and laboratory testing found significant electrolyte abnormalities. Severe gastrointestinal intolerance needing hospitalization is described in the literature as rare.
Why this belongs on a price site
Because gaps mostly are not medical decisions. A prepay term ends and the next one has not been bought. A shipment is late. A seller runs out of a strength. A month arrives where the subscription is the thing that gets cut.
Each of those is a treatment interruption with a restart attached to it, and the terms a seller attaches to its price decide how likely one is. That is a real cost of a cheap prepay nobody puts on the page, alongside the more familiar one that most people stop inside a year anyway.
What this page will not tell you
How to restart. There is guidance on re-escalating after an interruption, it depends on the product and how long the gap was, and it is not this desk’s to give.
What is safe to say is narrower: a gap is worth mentioning to whoever prescribes it before the next injection, rather than treating the restart as simply picking up where you left off. The dose is the variable everything else on this market is priced around, which is why what a seller charges as it climbs is worth knowing before a gap ever happens.
How much weight one case carries
Very little, as evidence. One patient cannot establish a rate, and severe cases like this one are reported precisely because they are unusual.
It carries more as a description. The sequence — long tolerance, short gap, full-dose restart, immediate trouble — is common enough on this market that most readers will recognize at least the first three steps.